Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Shannon McArdel"'
Autor:
Sivan Elloul, Anne-Sophie Dugast, Shannon McArdel, Enping Hong, Maegan Hoover, Laurence Turka, Zafira Castano, Arjun Reddy Bollampalli, Shannon Leonard, Ryan Pepi, Alex Nanna
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/305ceefb96694077a20dee7fde51ad88
Autor:
Sivan Elloul, Anne-Sophie Dugast, Shannon McArdel, Enping Hong, Arjun Bollampalli, Maegan Hoover, Sneha Pawar, Viral Amin, Kangjian Qiao, Christopher Ta, Laurence Turka, Thomas Wickham
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/8a6fd99397684961baede2a785881b1e
Autor:
Shannon C. Leonard, Maegan Hoover, Thomas Wickham, Shannon McArdel, Sivan Elloul, Laurence A. Turka, Arjun Bollampalli, Zafira Castaño, Nicholas Bayhi, Christopher L. Carpenter, Enping Hong, Douglas C. McLaughlin, Kelvin Muriuki, Sneha Pawar, Jennifer Mellen, Anne-Sophie Dugast
Publikováno v:
Cancer Immunology, Immunotherapy
Recombinant agonists that activate co-stimulatory and cytokine receptors have shown limited clinical anticancer utility, potentially due to narrow therapeutic windows, the need for coordinated activation of co-stimulatory and cytokine pathways and th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fbe885a6cd179d218e17e1b066a9ffe
https://pubmed.ncbi.nlm.nih.gov/34244816
https://pubmed.ncbi.nlm.nih.gov/34244816
Autor:
Anne-Sophie Dugast, Maegan Hoover, Sivan Elloul, Christopher Ta, Shannon McArdel, Kangjian Qiao, Arjun Bollampalli, Sneha Pawar, Enping Hong, Laurence A. Turka, Thomas Wickham, Viral Amin
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background Agonist antibodies and recombinant cytokines have had limited success in the clinic due to three factors: severe toxicity leading to a narrow therapeutic index, the diminished activity of an agonistic antibody compared with natural ligand,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::793b2af000a78135365c87e60e09a2c3
https://doaj.org/article/8a6fd99397684961baede2a785881b1e
https://doaj.org/article/8a6fd99397684961baede2a785881b1e
Autor:
Thomas Wickham, Jennifer Mellen, Shannon McArdel, Enping Hong, Maegan Hoover, Sivan Elloul, Torben Straight Nissen, Anne-Sophie Dugast, Douglas C. McLaughlin, Shannon C. Leonard, Christopher L. Carpenter, Arjun Bollampalli
Publikováno v:
Cancer Research. 79:3272-3272
Recombinant agonists that activate co-stimulatory and cytokine receptors have shown limited clinical activity perhaps due to 1) toxicity; 2) a need for coordinated activation of co-stimulatory and cytokine pathways; or 3) the failure of agonist antib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f1f3863c0ab3c68b0f1acedafbde673d
https://doi.org/10.1158/1538-7445.am2019-3272
https://doi.org/10.1158/1538-7445.am2019-3272
Publikováno v:
The Journal of Immunology. 196:71.2-71.2
CD48 (SLAMF2) is an adhesion and costimulation molecule constitutively expressed on hematopoietic cells, and a member of the signaling lymphocyte activation molecule family of immune receptors. Polymorphisms in CD48 have been linked to susceptibility
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e78a9f59239763f90065936e0c69e143
https://doi.org/10.4049/jimmunol.196.supp.71.2
https://doi.org/10.4049/jimmunol.196.supp.71.2